Skip to content

DEXMEDETOMIDINE in NORMAL VAGINAL DELIVERY

INTRAVENOUS Versus EPIDURAL DEXMEDETOMIDINE for ANALGESIA in NORMAL VAGINAL DELIVERY: A RANDOMIZED CONTROLED STUDY

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05840328
Enrollment
60
Registered
2023-05-03
Start date
2022-12-05
Completion date
2023-07-05
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless Vainal Labour

Brief summary

compare the effect of intravenous and epidural dexmetomidine as an adjuvant to local anesthetics in epidural labor analgesia in normal labor

Interventions

DRUGDexmedetomidine Injection [Precedex]

interventional drug will be administred either intravenously or epidurally

DRUGBupivacaine Injection

intervention drug will be administred epidurally

Sponsors

Menoufia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Full term (≥ 37 weeks) healthy primigravida parturients ASA2 * with single fetus scheduled for vaginal delivery * with cephalic presentation * requesting labor analgesia.

Exclusion criteria

* Allergy to dexmetomidine.(based on previous history) * Cardiac conduction abnormalities.(all degrees of heart block , tachyarrythmias) * Twins. * Malpresentation. * Preeclampsia or gestational hypertension * Uncontrolled diabetes HBA1c ≥ 6.5% * Uncontrolled renal failure * Uncontrolled liver disease * Bleeding tendency or coagulopathy. * Contraindication or patient refusal to epidural block. * Body mass index ≥ 35.

Design outcomes

Primary

MeasureTime frameDescription
pain reliefat 30 min after induction of blockVAS score from 0 to 10 will be assesed

Countries

Egypt

Contacts

Primary Contactmostafa S mansour, MD
mostafa.said@med.menofia.edu.eg01225484055

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026